J. Coronella

发表

The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of

Mark Horn, A. Kaspar, V. Doppalapudi, 2013 .

A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers

Christine Stewart, A. Timmer, R. Newman, 2020, Cancer biology & therapy.

TR1801‐ADC: a highly potent cMet antibody–drug conjugate with high activity in patient‐derived xenograft models of solid tumors

J. Hartley, Christine Stewart, François D'Hooge, 2019, Molecular oncology.

Evidence for an antigen-driven humoral immune response in medullary ductal breast cancer.

P. Telleman, R. Junghans, T. Truong, 2001, Cancer research.

The New Generation of Antibody Drug Conjugates

V. Blot, J. Coronella, Robyn Richardson, 2014 .

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells

E. Ostertag, Haibin Xi, D. Shedlock, 2022, Molecular therapy. Nucleic acids.

Ductal Carcinoma of the Breast Tumor-Infiltrating B Cells in Infiltrating Antigen-Driven Oligoclonal Expansion of

A. Stopeck, E. Hersh, K. Trevor, 2002 .

Catalytic function of Drosophila melanogaster glutathione S-transferase DmGSTS1-1 (GST-2) in conjugation of lipid peroxidation end products.

Sharda P. Singh, B. J. Cochrane, P. Zimniak, 2001, European journal of biochemistry.

46P Development of an allogeneic CAR-T targeting MUC1-C (MUC1, cell surface associated, C-terminal) for epithelial derived tumors

J. Baranda, D. Oh, D. Shedlock, 2022, Immuno-Oncology and Technology.

Antigen-Driven Oligoclonal Expansion of Tumor-Infiltrating B Cells in Infiltrating Ductal Carcinoma of the Breast1

A. Stopeck, E. Hersh, K. Trevor, 2002, The Journal of Immunology.

The Effect of Molecular Weight, PK, and Valency on Tumor Biodistribution and Efficacy of Antibody-Based Drugs.

Mark Horn, J. D. Del Rosario, A. Kaspar, 2013, Translational oncology.

Phase 1 study of P-PSMA-101 CAR-T cells in patients with metastatic castration-resistant prostate cancer (mCRPC).

T. Dorff, E. Ostertag, D. Oh, 2022, Journal of Clinical Oncology.

Amplification of IgG VH and VL (Fab) from single human plasma cells and B cells.

P. Telleman, R. Junghans, F. Ylera, 2000, Nucleic acids research.

Abstract 4629: Tumor penetration and retention of different sized FGFR4 targeting scaffolds

S. Pirie-Shepherd, R. Muchekehu, J. Coronella, 2012 .

120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications

E. Ostertag, D. Shedlock, Maximilian Richter, 2020, Journal for ImmunoTherapy of Cancer.

Selective activity against proliferating tumor endothelial cells by CVX-22, a thrombospondin-1 mimetic CovX-Body.

Kimberly J. Johnson, Lingna Li, N. Levin, 2009, Anticancer research.

123 P-MUC1C-ALLO1: A fully allogeneic stem cell memory T cell (TSCM) CAR-T therapy with broad potential in solid tumor

E. Ostertag, Yingying Zhao, D. Shedlock, 2021, Journal for ImmunoTherapy of Cancer.